© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Few compounds in the world of pharmaceutical excipients have experienced such a clear evolution as hydroxypropyl-β-cyclodextrin. Many years ago, researchers noticed that basic cyclodextrins could trap molecules in their donut-shaped architecture. For a long time this discovery lingered in the academic world, kept alive by advances in carbohydrate chemistry in Europe and Japan. The original β-cyclodextrin was handy but brought along issues with low water solubility and an unpredictable tendency to clump together, especially when used in medicinal solutions. Scientists didn’t just stick with the status quo; they modified cyclodextrins by attaching hydroxypropyl groups, which solved the solubility problem. Once these changes hit drug formulation labs in the 1970s and 1980s, hydroxypropyl-β-cyclodextrin started appearing more widely in both research settings and real-world products.
Many excipients show up in the industry, but hydroxypropyl-β-cyclodextrin stands out because it behaves reliably in water. It appears as a nearly white, free-flowing powder. Folks in the lab learn quickly just how easily it dissolves in water compared to its less-modified siblings. Chemically, its basket-like structure stays intact even after hydroxypropylation, which means it keeps the ability to form inclusion complexes with all kinds of drugs that otherwise resist dissolving. That boost in solubility directly affects how well active molecules get absorbed in the body, influencing both research and patient outcomes. Its bulky size and hydrophilic surface explain why it’s a gentle carrier for molecules sensitive to the environment.
Anyone working in formulation science knows there’s no room for vague descriptions in technical specifications or labeling. Hydroxypropyl-β-cyclodextrin comes with defined molecular substitution counts, usually measuring the average hydroxypropyl group per glucose unit. Purity gets tested by industry-standard chromatography, while moisture content and heavy metal traces are scrutinized to meet both legal and safety expectations. The typical labeling lists chemical name, degree of substitution, and batch-specific information. Assurance of low residual solvents and absence of harmful byproducts marks a major difference from older excipients; such transparency builds confidence among both researchers and regulators.
Simple addition of hydroxypropyl groups onto the β-cyclodextrin molecule isn’t a matter of mixing ingredients and hoping for the best. Instead, the process usually starts with alkaline treatment, introducing hydroxypropyl groups by reacting with propylene oxide. Reaction time, temperature, and base concentration determine how many hydroxypropyl groups end up on the molecule, changing solubility and safety with every shift in synthesis. Skilled technicians must carefully purify the product afterward, often using filtration, recrystallization, or chromatographic methods to ensure no unwanted substances linger. Small changes in process can swing the physical performance of the product, which every formulator learns firsthand after working through batch differences.
Ongoing modification of hydroxypropyl-β-cyclodextrin has pushed new boundaries in drug and food technology. Its reactive hydroxyl groups allow further changes—some groups have added sulfate or carboxymethyl moieties, tuning both charge and inclusion behavior. Scientists like to tinker, and small tweaks yield new flavors of cyclodextrins that can target specific pharmaceutical needs. Inclusion complex formation—a process where the hydrophobic drug nestles inside cyclodextrin’s cavity—remains the core attraction. Acids, bases, and enzymatic catalysts play roles here; clever chemistry students quickly grasp that temperature and pH can fine-tune the whole creation process.
Names change depending on where you work, but hydroxypropyl-β-cyclodextrin is often known as HP-β-CD, often accompanied by commercial names supplied by various chemical companies. In laboratory literature, the shorthand HPBCD or HPβCD pops up often, saving both space and time. By now, the compound has enough aliases to fill a small notebook, but the important point remains: no matter the name, the underlying structure and core properties do the heavy lifting in scientific work.
Safety holds a top spot in both pharmaceutical and food science. Hydroxypropyl-β-cyclodextrin has gone through more scrutiny than many other excipients, getting nods from the FDA and similar organizations elsewhere in the world. Strict standards dictate residual solvent levels, microbiological limits, and overall allowable impurities. Research into its absorption and excretion ensures that drug developers understand not just efficacy, but also any long-term risks—a big part of following regulatory guidance. Safety data isn’t just a box-checking operation; it comes from animal studies, followed by careful monitoring as it enters human clinical trials. Professionals working with the material pay close attention to dust generation and wear basic protective equipment, based on supplier recommendations and government safety sheets.
Hydroxypropyl-β-cyclodextrin doesn’t confine itself to just tablets or capsules. Researchers have found value in eyedrops, injectables, oral liquids, and even food products. This compound helps solubilize drugs like itraconazole and dexamethasone, which otherwise cause headaches for formulators trying to coax them into solution. Beyond human medicine, the same encapsulation magic appears in veterinary products and dietary supplements. Its role in stabilizing flavors or trapping unwanted molecules opens uses in food science, helping mask bitterness or off-aromas in everything from protein shakes to energy bars. Every application leans on the same qualities—water-solubility, complexation ability, low toxicity—that make it a go-to choice for product developers.
Ongoing R&D efforts dig into both the science and broader uses of hydroxypropyl-β-cyclodextrin. Pharmaceutical labs keep testing which actives benefit most from complexation; for instance, less soluble antihistamines and antibiotics see vast improvement. Scientists now explore customizing the degree of substitution to create tailored versions for new drugs, working to beat solubility hurdles in pipeline molecules. The growth of nanotechnology even sees HP-β-CD as a carrier for targeted drug delivery systems, with researchers layering additional targeting agents onto the base molecule. This field generates thousands of publications annually, reflecting the intense search for new applications, from gene therapy vehicles to improved antimicrobial formulations.
Toxicologists haven’t given hydroxypropyl-β-cyclodextrin a free pass, and that’s a good thing. Chronic animal studies address oral, intravenous, and topical exposure scenarios, showing low absorption in the gut due to its bulky structure and high hydrophilicity. Nevertheless, high doses may bring kidney concerns, especially in cases of intravenous injection. Human studies by regulatory agencies set exposure thresholds, balancing safety with the need for improved bioavailability. In real-world use, HP-β-CD displays good tolerance in both adults and children over short-term treatment cycles. Every new drug formulation containing this excipient goes through its own battery of safety studies, showing just how cautious the industry remains despite past successes.
Innovation continues to shape how hydroxypropyl-β-cyclodextrin turns up in labs and consumer products. With more drugs showing poor solubility, demand grows for better ways to get life-saving medicines into the body. Customized modifications open up even more possibilities by tuning the molecule for specific delivery systems, from oral films to nanoparticle formulations. Interest is rising in environmental uses as well—HP-β-CD shows promise for removing pollutants like pesticides or industrial solvents from water sources, a trend supported by early field tests. Applied research into food safety, personal care goods, and agricultural products all hint at a future where this carbohydrate derivative appears far beyond pharmacies and clinics. Ongoing safety monitoring, driven by thorough regulatory oversight, builds confidence and inspires researchers to keep exploring new horizons.
Most of us have dealt with bitter pills that seem impossible to swallow or dissolve. Pharmaceutical labs use hydroxypropyl-β-cyclodextrin to help with that problem. This modified sugar ring grabs onto difficult or gritty molecules like a soft molecular claw, trapping them inside its donut shape. When a drug sticks inside this ring, it often dissolves in water much better, helping your body to absorb more medication. This means a pill can start working quicker or taste less harsh, taking some misery out of being sick. The U.S. Food and Drug Administration lists hydroxypropyl-β-cyclodextrin as safe, so doctors and pharmacists trust it in many common medicines, including injections and eye drops.
Some illnesses need medicine to hit tough targets, like the brain or deep tissue. Water-hating drugs have trouble traveling through blood or cell walls, making treatment less effective. Hydroxypropyl-β-cyclodextrin steps in as a helper, making these stubborn compounds much more mobile. For example, in rare neurological diseases such as Niemann-Pick Type C, doctors use this ingredient to help medicines cross into the brain. That is real impact—a chemical helping to brighten a hopeless outlook.
Hydroxypropyl-β-cyclodextrin is not just for medicine. Food and beverage makers use it to lock away unpleasant flavors and keep delicate aromas from fading. In chewing gum or dairy, it holds onto strong tastes that would otherwise trigger a grimace. Fragrance companies take advantage of its ability to shield sensitive perfume notes until sprayed on your skin. My grandfather worked in quality control at a soft drink plant; taking apart problem batches, he’d show me how even the tiniest chemical tweak could keep a batch of cola from going flat or stale. Cyclodextrins belong to that invisible toolkit keeping familiar foods appealing.
Consumers want foods and medicines that stay fresh a long time, but nobody likes a label crowded with preservatives. Hydroxypropyl-β-cyclodextrin creates a stable barrier around active ingredients, protecting sensitive compounds from light, heat, and air. This keeps them from breaking down, so less extra chemical is needed. Research from the Journal of Pharmaceutical Sciences shows that vitamins and antioxidants last longer when paired with this molecule. The result is a shelf product that keeps its punch without a chemical aftertaste.
Scientists are always exploring new uses for hydroxypropyl-β-cyclodextrin. From helping to deliver gene therapies, to creating smart wound dressings, or stabilizing paint pigments—creativity keeps expanding the toolset. Transparency matters, so regulators keep a close eye on studies to make sure the benefits outweigh risks in each new project. Today, you can find this substance in everything from flavored water additives to experimental cancer treatments, proof that chemistry and safety can go hand in hand.
The real challenge lies in balancing convenience and long-term safety. Every time a new use comes up, industry and regulators have to check for allergic reactions or effects on sensitive groups. Doctors and researchers share reports, giving clear, honest data so families, patients, and consumers can make good choices. For now, hydroxypropyl-β-cyclodextrin stands as an example of turning basic sugar chemistry into a Swiss Army knife for health, safety, and modern living.
Anyone who’s checked the ingredient list on processed foods or pharmaceuticals might have stumbled across the tongue-twisting hydroxypropyl-β-cyclodextrin. The name alone sounds more at home in a laboratory than a kitchen, but this compound pops up in medicines, supplements, and even food products. For something so widespread, people naturally want to know if consuming it is actually safe.
From a scientific standpoint, cyclodextrins grab attention because they help dissolve substances that would otherwise clump together in liquid. Pharmaceutical companies use them to stabilize sensitive drugs, making some medications easier for us to swallow or absorb. In the food industry, they trap unwanted flavors or keep oils from going rancid. The hydroxypropyl-β variant does the job even better, showing improved water solubility and reduced likelihood of causing irritation compared to older versions.
After ingestion, most cyclodextrins don’t really waltz through our bodies. Our digestive enzymes rarely break them down, so much of what comes in goes right back out, mostly unchanged. Researchers say less than 1% gets absorbed. That’s a relief, since it reduces the chance of side effects from build-up in organs.
Looking at official guidance, organizations like the U.S. Food and Drug Administration and the European Food Safety Authority have both given hydroxypropyl-β-cyclodextrin their seal of approval within certain boundaries. As a food additive, it holds the status “generally recognized as safe” (GRAS), meaning experts have reviewed years of evidence and found no reason to worry at the doses commonly used.
Large doses can indeed cause loose stools or upset stomach — just like overdoing fiber — but that takes far more than the trace amounts in a piece of gum or a tablet. Animal studies, safety trials, and decades of observation haven’t found links to cancer or developmental problems. People who already face major digestive diseases should discuss new food additives with their doctors, though, since anything affecting gut absorption could add extra strain. For healthy adults and most kids, the data suggests regular dietary doses don’t present a risk.
Even though regulators and scientists have run the numbers, trust comes from more than studies and certifications. People deserve the chance to know exactly what’s in their food — not because every ingredient is a hidden danger, but because feeling informed reduces anxiety. Food makers and pharmacies have a responsibility to keep ingredient lists clear, push for continuous safety reviews, and disclose new findings. The best scenario keeps consumers in the loop without sounding the alarm over familiar ingredients with established safety records.
Looking ahead, safety isn’t just a check mark on a regulatory form. It’s a moving target. As companies create new uses for hydroxypropyl-β-cyclodextrin, ongoing research matters. Universities and watchdog groups need funding to track rare health impacts and check for subtle long-term effects. Doctors and pharmacists should field questions and share guidance with patients who are curious or cautious.
Hydroxypropyl-β-cyclodextrin appears safe for routine human consumption at levels found in foods and drugs. Confidence in that safety rests on continuing to ask questions, demanding clear answers, and keeping everyone — from consumers to scientists — in conversation.
Bringing a new medicine to market involves a lot more than a clever idea in a lab. Sometimes, the challenge doesn’t come from the drug itself, but from how to deliver it into the body where it can work. A big chunk of new drug molecules just won’t dissolve well in water. That tends to slow them down right out of the gate, especially if the goal involves getting a quick, reliable result for the patient.
Hydroxypropyl-Β-cyclodextrin, or HPβCD, helps make tough-to-dissolve drugs much more useful for real people. In practical terms, HPβCD acts like a chaperone for those stubborn compounds. It wraps around them and shuttles them through watery environments. Medicines based on lipophilic molecules (ones that love fat, not water) benefit the most from HPβCD. Some antifungals and heart medicines once struggled to reach the blood at all until this solution came along. Researchers at academic centers, as well as the FDA, confirm this effect is well documented.
No one wants to pick up a prescription only to find it needs a mini-lab’s worth of storage and care, or that it loses its punch before the next refill. HPβCD steps in to help keep medicines steady and ready for use much longer. Even drugs that fall apart in light, heat, or the acidic environment of the stomach stand a better chance of holding together until they cross into the bloodstream. I’ve seen first-hand how patients living with chronic illnesses count on that reliability—they don’t have to toss their pills or liquids halfway through a course due to surprise spoilage.
It’s rare that a pharmaceutical additive offers a strong safety record and fits the strict standards set by regulators. HPβCD stands apart because it gets along well with living tissue; it doesn’t spark allergic reactions or break down into anything toxic in the body. Decades of clinical use and research back this up. In my experience, family members taking antifungal drugs containing HPβCD never showed side effects from the additive, even after months of use.
Some oral medicines taste awful, which leads to skipped doses, especially in kids. HPβCD can make tablets and syrups less bitter. It grabs onto bad-tasting molecules so the mouth doesn’t notice them as much. On top of that, medications that once required oily or irritating injectable solutions can be reformulated into watery, comfortable injections with HPβCD—this is a clear upgrade for people needing regular shots.
As more new drugs keep pushing the limits of chemistry, the industry can’t ignore the roadblocks of poor solubility, stability, or taste. HPβCD keeps delivering ways around those obstacles. If more companies focus on this technology, new and old medicines alike can perform better, keep patients safer, and reduce waste all the way from the factory to the pharmacy shelf. The goal stays the same: medicines that help people live better, made possible by smart and proven helpers like Hydroxypropyl-Β-Cyclodextrin.
Lots of labs and companies rely on Hydroxypropyl-Β-Cyclodextrin for its ability to wrap up active pharmaceutical compounds, making them easier for our bodies to use. It looks like a fine, almost floury powder. Even a slight bit of extra moisture or wrong storage can send an expensive batch straight to waste.
From my years working behind the bench, I’ve seen how small slip-ups in storage knock expensive projects off track. This compound pulls moisture right out of the air—a trait called hygroscopicity that chemists always stay wary of. Leave a jar open, you’ll spot clumps in no time, which means it’s started breaking down. That can seriously mess up both research and manufacturing, since purity levels drop and the powder might even start smelling odd as it ages.
Hydroxypropyl-Β-Cyclodextrin also doesn’t deal well with strong light or rising temperatures. Sunlight streaming through a window, or heat from a radiator, ramp up the risk of chemical changes. Plenty of substances change color over time; that’s not just a cosmetic issue. The material inside could be turning into something untested, making the final product unsafe or unreliable. A stable, well-labeled environment helps you sidestep those costly issues.
Storing Hydroxypropyl-Β-Cyclodextrin is less about fancy gear and more about solid habits. You only really need a dark, cool cupboard—preferably away from lab activity, break rooms, or window ledges. A temperature range between 15 and 25°C (59–77°F) keeps your powder safe from heat and melting. Don’t forget to double-check that the area’s humidity stays low; dry air is key.
A lot of people use amber glass jars, which block out damaging light. These jars seal with a tight plastic or Teflon lid, keeping out that stubborn water vapor. I’ve worked in labs where old plastic bags and loose lids led to ruined samples. An investment in decent containers makes a real difference, saving both time and money down the road.
It pays to record each opening. Every dip into the container lets in a small amount of moisture or contaminants. A log on the side of the jar helps catch problems before they get bigger, like noticing faster-than-usual clumping or discoloration. Setting the powder on labeled shelves—away from incompatible chemicals—prevents accidental mixing.
Some manufacturers recommend extra layers: adding a few silica gel pouches around the bottle, for instance, or placing the powder in a double-bagged setup inside the main container. Just don’t overcomplicate it; the real enemy is carelessness, not the absence of a particular gadget.
Before I grab anything from storage, I make sure my gloves are fresh and dry. Even fingerprints can start a chain reaction in sensitive powders. Any leftover sample should go back into storage right away. I keep the lid on even while weighing, using a funnel or spatula that has seen the inside of a dishwasher recently. Small things add up—personal experience confirms the old saying: “A minute’s slackness leads to a month’s setback.”
Taking storage seriously shows care for your co-workers, your employer’s investment, and—if this powder will end up in medicine—public health. Adopting a consistent, careful approach means Hydroxypropyl-Β-Cyclodextrin works as intended, every time it’s called upon.
Hydroxypropyl-Β-cyclodextrin gets tossed around in conversations about drug formulations and food technology. Having spent long hours reviewing pharmaceutical protocols and talking with clinicians, I’ve seen how confusion about dosages crops up for anything outside the mainstream, especially when the same material finds a home in both the lab and consumer products. Here’s what’s clear: dosage never amounts to guesswork in science or medicine. Recommendations reflect a blend of human study, animal trials, and decades of chemical safety data.
Researchers typically use hydroxypropyl-Β-cyclodextrin as a solubilizer or stabilizer—so, its dose often depends on the “cargo” molecule hitching a ride. In oral and intravenous drug applications, published clinical trials report dosages ranging from 2 grams to 16 grams per day for adults. For example, a 2017 clinical trial assessing treatments for Niemann-Pick disease C used doses as high as 2000 mg/kg/week intravenously in children with supervision by neurologists and medical geneticists. Another study on food additives found that hydroxypropyl-Β-cyclodextrin was still considered safe at dietary exposures up to 5 mg/kg body weight per day among adults.
Lab studies don’t always forecast real-life situations perfectly. Human experience counts the most. For context, regulatory agencies rely on large safety margins when giving their nod—I recall the European Food Safety Authority setting limits between 2 and 10 mg/kg body weight per day for daily intake in average adults. Higher pharmaceutical doses always require careful medical oversight because too much cyclodextrin in the bloodstream can cause kidney strain, especially in folks with existing kidney issues.
Back in pharmacy school, my instructors hammered home the idea of “the dose makes the poison.” Cyclodextrins look benign, but if a person has kidney issues or takes large amounts, the molecule can build up and cause problems. I’ve seen cases where ignoring this principle leads to a scramble in the clinic. For food and supplements, lower limits keep things manageable with minimal risk. Hospital and clinical use opens another world that demands calculators, lab tests, and close follow-up—any dose higher than 10 mg/kg daily steps into the territory of prescription-only use for a reason.
People sometimes search for information online and end up with bits and pieces from different sources. The safest path is open communication with health professionals. Trusted chemists and physicians go back to research and official guidelines, not online anecdotes. If a patient wants to use a supplement containing hydroxypropyl-Β-cyclodextrin, reading the label is important, but so is checking for guidance from dietitians, pharmacists, or regulatory agencies.
Food and pharmaceutical makers stay on the safe side by using the lowest effective amount to get the job done—whether that’s delivering a life-saving medicine or blending with a flavor compound. Regulators like the FDA and EFSA demand transparency for a reason. If there’s a formula, it should state the exact concentration, along with any relevant warnings. That’s not clutter; that’s consumer protection. Based on what I’ve seen in practice, everyone from factory techs to clinical pharmacists benefits from solid information and teamwork.
Dosing hydroxypropyl-Β-cyclodextrin isn’t a casual calculation. Real-world experience, regulatory advice, published human studies, and individual health profiles shape the best answer. Low amounts in food stay under 10 mg/kg per day for most people. Medically supervised therapy can push doses much higher, strictly in a clinic. Getting this right keeps people safe and supports every practical use, from pharmacy to shelf-stable food.
| Names | |
| Preferred IUPAC name | (2R,3S,4S,5R,6R)-2-(Hydroxypropoxy)-6-(hydroxymethyl)oxane-3,4,5-triol β-D-glucopyranosyl-(1→4)-[β-D-glucopyranosyl-(1→4)]₆-β-D-glucopyranoside |
| Other names |
Hydroxypropyl beta-cyclodextrin 2-Hydroxypropyl-beta-cyclodextrin HP-β-CD HPBCD 2-HP-β-CD Hydroxypropylated beta cyclodextrin Hydroxypropyl beta dextrine |
| Pronunciation | /haɪˌdrɒksiˈproʊpɪl ˌbeɪtə ˌsaɪkloʊˈdɛkstrɪn/ |
| Identifiers | |
| CAS Number | 128446-35-5 |
| Beilstein Reference | 13609902 |
| ChEBI | CHEBI:119495 |
| ChEMBL | CHEMBL1201560 |
| ChemSpider | 5262331 |
| DrugBank | DB11262 |
| ECHA InfoCard | 03aa2d41-c50b-4cb2-82fa-5fc7e1b19603 |
| EC Number | 94035-02-6 |
| Gmelin Reference | 358664 |
| KEGG | C18647 |
| MeSH | D018444 |
| PubChem CID | 444041 |
| RTECS number | GGW161500 |
| UNII | L1O95O2P26 |
| UN number | UN number is not assigned |
| Properties | |
| Chemical formula | C42H70O35 |
| Molar mass | 1396.11 g/mol |
| Appearance | white or almost white powder |
| Odor | Odorless |
| Density | 0.5 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -2.8 |
| Acidity (pKa) | 12.5 |
| Basicity (pKb) | 7.86 |
| Refractive index (nD) | 1.460 |
| Viscosity | Viscosity: < 100 mPa.s (20 °C, 30% in water) |
| Dipole moment | 2.73 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 355.5 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | V09AX10 |
| Hazards | |
| Main hazards | Not a hazardous substance or mixture. |
| GHS labelling | GHS labelling of Hydroxypropyl-Β-Cyclodextrin: "Not a hazardous substance or mixture according to the Globally Harmonized System (GHS). |
| Pictograms | GHS07 |
| Signal word | No signal word |
| Hazard statements | No hazard statements. |
| Precautionary statements | Keep container tightly closed. Store in a dry place. Wash hands thoroughly after handling. Wear protective gloves/eye protection. |
| NFPA 704 (fire diamond) | NFPA 704: 1-0-0 |
| Flash point | > 199.1 °C |
| Autoignition temperature | 400 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat) > 10,000 mg/kg |
| LD50 (median dose) | > 6,000 mg/kg (rat, oral) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/m³ |
| Related compounds | |
| Related compounds |
Beta-cyclodextrin Methyl-β-cyclodextrin Sulfobutylether-β-cyclodextrin Hydroxyethyl-β-cyclodextrin Gamma-cyclodextrin Alpha-cyclodextrin |
